129 related articles for article (PubMed ID: 38895868)
1. The Prognostic Implications of Neutrophil-to-Lymphocyte Ratio in Olfactory Neuroblastoma.
Mocharnuk J; Daniels KE; Filimonov A; North LM; Gardner PA; Wang EW; Snyderman CH
Otolaryngol Head Neck Surg; 2024 Jun; ():. PubMed ID: 38895868
[TBL] [Abstract][Full Text] [Related]
2. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
3. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.
Van Gompel JJ; Giannini C; Olsen KD; Moore E; Piccirilli M; Foote RL; Buckner JC; Link MJ
J Neurol Surg B Skull Base; 2012 Oct; 73(5):331-6. PubMed ID: 24083125
[TBL] [Abstract][Full Text] [Related]
5. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence and disease progression in patients with positive-margin olfactory neuroblastoma following primary resection.
Bauman MMJ; Graves JP; Haller TJ; McMillan RA; Routman DM; Raghunathan A; Stokken JK; Link MJ; Moore EJ; Choby G; Van Gompel JJ
J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38518294
[TBL] [Abstract][Full Text] [Related]
7. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
8. Development of an evaluation and treatment strategy for olfactory neuroblastoma: a review of evidence from large-scale studies, including population-based and multicenter studies, and meta-analyses.
Ariizumi Y; Asakage T
Jpn J Clin Oncol; 2024 May; ():. PubMed ID: 38762332
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
[TBL] [Abstract][Full Text] [Related]
10. Surgical Treatment of Olfactory Neuroblastoma: Major Complication Rates, Progression Free and Overall Survival.
Wertz A; Hollon T; Marentette LJ; Sullivan SE; McHugh JB; McKean EL
J Neurol Surg B Skull Base; 2018 Apr; 79(2):151-155. PubMed ID: 29868319
[No Abstract] [Full Text] [Related]
11. Olfactory Neuroblastomas: What Actually Happens in the Long-Term?
Mantsopoulos K; Koch M; Iro H; Constantinidis J
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566413
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
13. Esthesioneuroblastoma (Olfactory Neuroblastoma): Overview and Extent of Surgical Approach and Skull Base Resection.
Karp EE; Gompel JJV; Choby G
J Neurol Surg Rep; 2022 Jul; 83(3):e80-e82. PubMed ID: 35832684
[TBL] [Abstract][Full Text] [Related]
14. Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.
Spielman DB; Liebowitz A; Grewal M; Safi C; Overdevest JB; Iloreta AM; Youngerman BE; Gudis DA
World J Otorhinolaryngol Head Neck Surg; 2022 Mar; 8(1):66-72. PubMed ID: 35619935
[TBL] [Abstract][Full Text] [Related]
15. Complications of Advanced Kadish Stage Esthesioneuroblastoma: Single Institution Experience and Literature Review.
Palejwala SK; Sharma S; Le CH; Chang E; Lemole M
Cureus; 2017 May; 9(5):e1245. PubMed ID: 28620574
[TBL] [Abstract][Full Text] [Related]
16. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
17. Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma.
Wu L; Liu H; Liu H
Clin Neuropathol; 2023; 42(2):47-53. PubMed ID: 36708210
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract][Full Text] [Related]
19. Recurrence morbidity of olfactory neuroblastoma.
Melder K; Mace JC; Choby G; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Fung NK; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; Patel C; Patel Z; Celda MP; Pinheiro-Neto CD; Snyderman C; Thorp BD; Van Gompel JJ; Zenonos G; Zwagerman NT; Sanusi O; Wang EW; Geltzeiler M
Int Forum Allergy Rhinol; 2024 Apr; ():. PubMed ID: 38567900
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
